5-Pyridin-2-yl-1H-pyrazole-3-carboxylic acid - CAS 374064-02-5
Catalog: |
BB023275 |
Product Name: |
5-Pyridin-2-yl-1H-pyrazole-3-carboxylic acid |
CAS: |
374064-02-5 |
Synonyms: |
3-(2-pyridinyl)-1H-pyrazole-5-carboxylic acid; 3-pyridin-2-yl-1H-pyrazole-5-carboxylic acid |
IUPAC Name: | 3-pyridin-2-yl-1H-pyrazole-5-carboxylic acid |
Description: | 5-Pyridin-2-yl-1H-pyrazole-3-carboxylic acid (CAS# 374064-02-5) is a useful research chemical. |
Molecular Weight: | 189.17 |
Molecular Formula: | C9H7N3O2 |
Canonical SMILES: | C1=CC=NC(=C1)C2=NNC(=C2)C(=O)O |
InChI: | InChI=1S/C9H7N3O2/c13-9(14)8-5-7(11-12-8)6-3-1-2-4-10-6/h1-5H,(H,11,12)(H,13,14) |
InChI Key: | SJBWHTBPIJXUFP-UHFFFAOYSA-N |
Boiling Point: | 525.8 °C at 760 mmHg |
Purity: | 97 % |
Density: | 1.432 g/cm3 |
MDL: | MFCD05170030 |
LogP: | 1.16990 |
GHS Hazard Statement: | H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] |
Precautionary Statement: | P264, P280, P305+P351+P338, and P337+P313 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
EP-3566055-A1 | Methods for the treatment of neurological disorders | 20170106 |
US-2018193325-A1 | Methods for the treatment of neurological disorders | 20170106 |
WO-2018129403-A1 | Methods for the treatment of neurological disorders | 20170106 |
US-10973810-B2 | Methods for the treatment of neurological disorders | 20170106 |
US-10821104-B2 | Five-membered heterocyclic amides WNT pathway inhibitor | 20151207 |
PMID | Publication Date | Title | Journal |
20932746 | 20101115 | Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution | Bioorganic & medicinal chemistry letters |
15732974 | 20050307 | Iridium(III) complexes with orthometalated quinoxaline ligands: subtle tuning of emission to the saturated red color | Inorganic chemistry |
14594314 | 20031021 | Syntheses and remarkable photophysical properties of 5-(2-pyridyl) pyrazolate boron complexes; photoinduced electron transfer | Chemical communications (Cambridge, England) |
Complexity: | 222 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 189.053826475 |
Formal Charge: | 0 |
Heavy Atom Count: | 14 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 189.053826475 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 78.9 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.7 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
-
[714971-28-5]
(S)-N-Boc-3-(Hydroxymethyl)morpholine
-
[63089-56-5]
4-Amino-1,2,3,5,6,7-hexahydro-s-indacene
-
[1408282-26-7]
8-Fluoro-4,5-dihydro-1H-azepino[5,4,3-CD]indol-6(3H)-one
-
[84030-20-6]
1,3,4,6,7,8-Hexahydro-1-methyl-2H-pyrimido[1,2-a]pyrimidine
-
[1393527-23-5]
Phosphoric acid 6,6'-di(9-anthryl)-1,1'-spirobiindan-7,7'-diyl ester
-
[784-04-3]
9-Acetylanthracene
INDUSTRY LEADERS TRUST OUR PRODUCTS